Nephrology
News
Rosuvastatin again linked with risks to kidneys
Practice should more often heed FDA-recommended rosuvastatin dosages for patients with severe chronic kidney disease and step up monitoring for...
Conference Coverage
SGLT2 inhibitors cut AFib risk in real-word analysis
Observational data add to a growing link between SGLT2 inhibitor treatment and atrial fibrillation prevention in people with type 2 diabetes.
News
Mixing BP meds with NSAID may be ‘triple whammy’ for kidneys
In the absence of additional risk factors, there was no indication of an elevated risk for AKI when an ACE inhibitor and NSAID are combined.
News
Lowering BP according to newest guidance would cut CV events
Two-thirds of patients would need new or intensified hypertension treatment to reach an SBP less than 120 mm Hg, as set in the 2021 KDIGO...
News
Opting out of dialysis not instant death sentence for kidney disease
The study “dispels the notion that conservative care for kidney failure means a grim and near-immediate death.”
News
Community genetic testing prompts behavior change in patients
“These two measurements – the change in blood pressure and increased kidney function tests – act as hallmarks for detecting beneficial lifestyle...
News
Biomarkers predict cardiovascular risk in chronic kidney disease patients
New models to stratify atherosclerotic cardiovascular disease risk may improve shared decision-making.
Latest News
No COVID vax, no transplant: Unfair or good medicine?
Is removing them from the list unfair and cruel, or simply business as usual?
News
Allopurinol found safe in patients with concomitant gout, CKD
Despite earlier concerns, a study has found no sign of increased mortality with allopurinol therapy in patients with gout and chronic kidney...
Conference Coverage
Oral daprodustat safely improves anemia in chronic kidney disease
“What’s out there [for daprodustat] seems very encouraging,” according to a nephrologist.